- Previous Close
80.50 - Open
80.50 - Bid --
- Ask --
- Day's Range
80.50 - 84.14 - 52 Week Range
73.25 - 113.00 - Volume
1,183 - Avg. Volume
3,145 - Market Cap (intraday)
1.916B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
448.39 - EPS (TTM)
0.18 - Earnings Date Feb 10, 2025 - Feb 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 19, 2013
- 1y Target Est
--
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.
www.bafnapharma.com363
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BAFNAPH.NS
View MorePerformance Overview: BAFNAPH.NS
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BAFNAPH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BAFNAPH.NS
View MoreValuation Measures
Market Cap
1.92B
Enterprise Value
2.09B
Trailing P/E
448.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.33
Price/Book (mrq)
2.31
Enterprise Value/Revenue
1.46
Enterprise Value/EBITDA
25.69
Financial Highlights
Profitability and Income Statement
Profit Margin
0.19%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.44B
Net Income Avi to Common (ttm)
2.73M
Diluted EPS (ttm)
0.18
Balance Sheet and Cash Flow
Total Cash (mrq)
13.96M
Total Debt/Equity (mrq)
30.17%
Levered Free Cash Flow (ttm)
--